Japan’s Mitsui, Rohto Said Near Deal for Chinese Medicine Firm
- Agreement on majority stake could happen as soon as next week
- A potential deal could value Eu Yan Sang at about $800 million
The Eu Yan Sang International website.
This article is for subscribers only.
A group including Japan’s Mitsui & Co. and Rohto Pharmaceutical Co. is nearing a deal to acquire a majority stake in medicine and health-care company Eu Yan Sang International Ltd., people familiar with the matter said.
The Mitsui and Rohto group has emerged as the likeliest buyer of the stake after outbidding others, the people said. The Japanese companies are finalizing details of a transaction that could be signed as early as next week, according to the people, who asked not to be identified because the matter is private.